Last Week’s Top-3 Most Read Posts On Multiple Sclerosis



Read the Articles Here:

Novartis’ MS Drug Gilenya Prevents Activation of Key Immune Cells in Study

Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results

Could Remyelination Be Achieved in MS Using an Anti-Inflammatory Treatment?

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This